Commonwealth Equity Services LLC Increases Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Commonwealth Equity Services LLC lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 3,263.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 314,043 shares of the medical instruments supplier's stock after purchasing an additional 304,707 shares during the period. Commonwealth Equity Services LLC owned 0.16% of DENTSPLY SIRONA worth $5,961,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Pacer Advisors Inc. lifted its stake in DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock valued at $85,478,000 after purchasing an additional 4,473,972 shares during the last quarter. Cooke & Bieler LP increased its holdings in DENTSPLY SIRONA by 24.3% in the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock worth $174,101,000 after acquiring an additional 1,794,391 shares during the last quarter. JPMorgan Chase & Co. raised its stake in DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after acquiring an additional 1,244,326 shares during the period. Invenomic Capital Management LP purchased a new stake in DENTSPLY SIRONA during the third quarter valued at about $23,724,000. Finally, National Bank of Canada FI raised its stake in shares of DENTSPLY SIRONA by 85.8% during the 3rd quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier's stock valued at $44,059,000 after purchasing an additional 751,800 shares during the period. 95.70% of the stock is owned by institutional investors.

Remove Ads

Insider Buying and Selling

In related news, Director Gregory T. Lucier acquired 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. 0.52% of the stock is currently owned by insiders.

DENTSPLY SIRONA Stock Performance

XRAY traded up $0.03 during midday trading on Wednesday, hitting $15.60. 2,057,311 shares of the company traded hands, compared to its average volume of 2,997,746. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 52 week low of $14.78 and a 52 week high of $33.42. The firm has a market capitalization of $3.10 billion, a PE ratio of -7.54, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The company's 50-day moving average is $17.81 and its 200 day moving average is $20.33.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.10%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA's payout ratio is currently -14.07%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on XRAY shares. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and decreased their price target for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. StockNews.com downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Evercore ISI reiterated an "in-line" rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Wells Fargo & Company lowered their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Finally, Morgan Stanley reduced their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a research report on Tuesday, December 17th. Twelve investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $23.33.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.